SCHEMBL7547951

SCHEMBL7547951

CN(c1nccc(-n2cnc3ccccc32)n1)C1CN(C(=O)Nc2cccc3ccccc23)CCN1C(=O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7547667 0.85 LCK (0.69) LCK
SCHEMBL7547581 0.84 LCK (0.53) LCK
SCHEMBL7547945 0.84 LCK (0.62) LCK
SCHEMBL7569722 0.84 LCK (0.79) LCK
SCHEMBL7544896 0.84 LCK (0.79) LCK
SCHEMBL7867944 0.84 LCK (0.79) LCK
SCHEMBL7569729 0.84 LCK (0.79) LCK
SCHEMBL7506519 0.81 LCK (0.64) LCK
SCHEMBL7588831 0.79 LCK (0.69) LCK
SCHEMBL7542138 0.79 LCK (0.62) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 US disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed